ATRA
Atara Biotherapeutics, Inc.Company with tickers: ATRA
CIK
1604464
CUSIP
046513206
Shares Outstanding
9,010,172
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $516,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $164,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Operating Income | $-3,369,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Net Income | $-4,145,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Basic) | $-0.29 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Diluted) | $-0.29 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |